Sheaff Brock Investment Advisors’s Neos Therapeutics, Inc NEOS Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,000	Closed	-$49K	–	547
2018 Q3	$49K	Sell	10,000 -20,000	-67%	-$113K	﹤0.01%	514
2018 Q2	$188K	Sell	30,000 -43,998	-59%	-$328K	0.02%	476
2018 Q1	$614K	Sell	73,998 -6,002	-8%	-$57.3K	0.06%	217
2017 Q4	$816K	Sell	80,000 -20,000	-20%	-$192K	0.11%	185
2017 Q3	$915K	Buy	+100,000	New	+$760K	0.12%	162
2017 Q2	–	Sell	-30,000	Closed	-$216K	–	663
2017 Q1	$216K	Buy	+30,000	New	+$186K	0.03%	486

Other funds holding NEOS

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sheaff Brock Investment Advisors's NEOS Position: Q4 2018 in Review

Sheaff Brock Investment Advisors sold out of Neos Therapeutics, Inc (NEOS) in Q4 2018, closing a stake of 10,000 shares — an estimated $49K sold.

Sheaff Brock Investment Advisors first reported a position in NEOS in Q1 2017 and held it in 6 quarters. The position peaked at $915K in Q3 2017. 63 funds tracked by Wall St. Rank hold NEOS as of Q4 2018.

Sheaff Brock Investment Advisors reported no remaining Neos Therapeutics, Inc position as of Q4 2018 after selling out during the quarter.
Sheaff Brock Investment Advisors sold 10,000 Neos Therapeutics, Inc shares in Q4 2018, an estimated $49K.
Sheaff Brock Investment Advisors first reported a position in Neos Therapeutics, Inc in Q1 2017 and held it in 6 quarters.
Sheaff Brock Investment Advisors's Neos Therapeutics, Inc position peaked at $915K in Q3 2017.
63 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2018.

Based on Sheaff Brock Investment Advisors's 13F filing for Q4 2018, filed 28 Jan 2019.